- AstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker’s Cancer DrugAnd it'll pay $1.4 billion upfront for the drug.
- Eli Lilly, AstraZeneca's Alzheimer's Drug Flop Is the Latest Disappointment in a Frustrating DiseaseThe story of Alzheimer's drug development is one of perpetual tragedy and setbacks.
- This Company Beat the Odds to Become One of the World's Most 'Innovative' Drug GiantsBritish drug maker AstraZeneca had some tricks up its sleeves.
- Why Drug Giant AstraZeneca's Stock Soared More Than 9% on FridayAn unexpected cancer trial success got investors' attention.
- Big Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts5 pharma giants announced layoffs.
- Merck to Axe Jobs As Part of New Research FocusPart of a new restructuring.
- The Feds Say This Popular Nasal Spray Flu Vaccine Doesn't WorkIt was effective just 3% of the time for kids.
Skip to Content